Cephalon chairman takes leave of absence

pharmafile | September 2, 2010 | Appointment | Research and Development, Sales and Marketing Cephalon, appointment, research and development, sales and marketing 

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect.

The company said he was expected to return to helm the company later this year.

Meanwhile Cephalon’s chief operating officer J Kevin Bushi will temporarily take on Frank’s responsibilities.

Prior to assuming the newly-created role of chief operating officer earlier this year, Mr Buchi served as the company’s chief financial officer for 14 years, and in total has been with Cephalon for almost 20 years.

William Egan, Cephalon’s presiding director, said, “Kevin has the complete confidence and full support of the board as he manages the company’s operations until Frank’s anticipated return later this year.

“In order to provide Frank and his family the privacy that they deserve, we will not be commenting further.”

Related Content

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

funk

Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content